Conclusion: Understanding and managing retatrutide side effects Retatrutide is an emerging blockbuster medication for weight management, which shows promising results, but it is an investigational drug with a side effect profile similar to other medications in its class
First Generic GLP-1 for Obesity Gains FDA Approval The FDA approved Tevas generic Saxenda, the first GLP-1 drug for weight loss, expanding access to obesity treatment
Lambda Therapeutic Research offers a wide range of bioanalytical capabilities specializing in cell-based assays, biomarkers, immunogenicity, and pharmacokinetics (PK)
Scenario Analysis: Post-2025 Delivery System IP Strategy Under the New Rules The regulatory and legal environment for pharmaceutical delivery-system IP has changed materially since 2023
People who have a low income and are eligible for Medicare programs that reduce drug costs (such as the Extra Help program) will not get that discount for the Bridge program